There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of Molnupiravir
CAS No.: 2492423-29-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Molnupiravir is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 2492423-29-5 |
Formula : | C13H19N3O7 |
M.W : | 329.31 |
SMILES Code : | O[C@H]1[C@@](O[C@H](COC(C(C)C)=O)[C@H]1O)(N2C(=O)N/C(=N\O)/C=C2)[H] |
MDL No. : | MFCD32663515 |
InChI Key : | HTNPEHXGEKVIHG-QCNRFFRDSA-N |
Pubchem ID : | 145996610 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Danger |
Hazard Statements: | H315-H319-H228 |
Precautionary Statements: | P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Class: | 4.1 |
UN#: | 1325 |
Packing Group: | Ⅱ |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
A549-hACE2 cells | 2.8 μM | 48 hours | Evaluate the inhibitory effect of Molnupiravir on SARS-CoV-2 nLUC replication, showing dose-dependent antiviral effects | Sci Transl Med. 2022 May 4;14(643):eabm3410 |
Calu-3 cells | 10 μM | 48 hours | To validate the antiviral activity of Molnupiravir against SARS-CoV-2 in Calu-3 cells, results showed significant antiviral effects. | Nature. 2022 Apr;604(7904):134-140 |
human airway organoids (hAOs) | 10 μM | Validate the antiviral activity of Molnupiravir in hAOs. Results showed that 10 μM Molnupiravir reduced viral RNA levels by >90%. | Cell Res. 2022 Mar;32(3):322-324 | |
human lung epithelial Calu-3 cells | 1 μM, 10 μM | 48 hours | Evaluate the antiviral activity of Molnupiravir against the Omicron variant. Results showed that 1 μM Molnupiravir reduced viral RNA by 70.4%, and complete inhibition was achieved at 10 μM and higher concentrations. | Cell Res. 2022 Mar;32(3):322-324 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Syrian Gold hamsters | SARS-CoV-2 infection model | Oral | 250 mg/kg | Twice daily for 6 days | Evaluate the inhibitory effect of drug combination on SARS-CoV-2 replication, results showed combination treatment significantly reduced viral load | iScience. 2022 May 20;25(5):104293. |
Ferrets | Upper respiratory infection model | Oral | 5 mg/kg | Twice daily for 4 days | Assess the therapeutic effect of EIDD-1931 on upper respiratory infection, showing significant reduction in viral shedding and prevention of transmission. | Nat Commun. 2022 Jul 29;13(1):4416. |
Sprague-Dawley rats | Pregnant rat model | Intravenous injection | 100 mg/kg | Single dose | To investigate the pharmacokinetics and placental transfer of EIDD-1931 in pregnant rats. Results showed that EIDD-1931 rapidly crosses the placental barrier into the fetus, and its concentration in the fetus was higher than the IC50 for SARS-CoV-2. | EBioMedicine. 2023 Sep;95:104748 |
C57BL/6 mice | SARS-CoV infection model | Oral | 50, 150, 500 mg/kg | Every 12 hours until the end of the study | Evaluate prophylactic and therapeutic efficacy of EIDD-2801 against SARS-CoV, significantly reduced weight loss and lung hemorrhage, decreased virus titer | Sci Transl Med. 2020 Apr 29;12(541):eabb5883 |
Ferrets | SARS-CoV-2 infection model | Oral gavage | 5 mg/kg or 15 mg/kg | Twice daily, continued until four days after infection | To evaluate the therapeutic effect of oral MK-4482/EIDD-2801 on SARS-CoV-2 infection in ferrets, results showed significant reduction in upper respiratory tract viral load and complete suppression of virus transmission to untreated contact animals. | Nat Microbiol. 2021 Jan;6(1):11-18 |
Ferrets | Upper respiratory infection model | Oral | 5 mg/kg | Every 12 hours for 4 days | Assess the therapeutic effect of Molnupiravir on upper respiratory infection, showing significant reduction in viral shedding and prevention of transmission. | Nat Commun. 2022 Jul 29;13(1):4416 |
Syrian hamsters | SARS-CoV-2 infection model | Oral gavage | 250 mg/kg | Dosed every 12 hours for 3 days | To assess the inhibitory effect of MK-4482 on SARS-CoV-2 replication, results showed that MK-4482 significantly reduced viral lung loads and pathology | Nat Commun. 2021 Apr 16;12(1):2295 |
BALB/C mice | SARS-CoV-2 Beta variant infection model | Oral | 50 mg/kg and 150 mg/kg | Twice daily for 2 days | To evaluate the antiviral efficacy of Molnupiravir in a mouse model of SARS-CoV-2 Beta variant infection, results showed significant reduction in viral titers and lung inflammation. | Nature. 2022 Apr;604(7904):134-140 |
Balb/c mice | HCoV-OC43 infection model | Oral | 200 mpk | Once daily for 4 days | Evaluate the therapeutic efficacy of Molnupiravir against HCoV-OC43 infection, showing significant reduction in viral load. | Signal Transduct Target Ther. 2023 Sep 22;8(1):360 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT06615869 | Healthy | PHASE1 | COMPLETED | 2023-03-15 | QPS-MRA, LLC-Early Phase (Site... More >> 0002), South Miami, Florida, 33143, United States Less << |
NCT05386758 | Renal Impairment | PHASE1 | COMPLETED | 2023-03-01 | Velocity Clinical Research, Ha... More >>llandale Beach ( Site 0005), Hallandale Beach, Florida, 33009, United States|Advanced Pharma CR, LLC ( Site 0004), Miami, Florida, 33147, United States|Genesis Clinical Research, LLC ( Site 0003), Tampa, Florida, 33603, United States|Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology ( Site 0001), Philadelphia, Pennsylvania, 19107, United States Less << |
NCT05386589 | Hepatic Impairment | PHASE1 | COMPLETED | 2023-01-05 | Research Centers of America ( ... More >>Hollywood ) ( Site 0002), Hollywood, Florida, 33024, United States|Clinical Pharmacology of Miami ( Site 0003), Miami, Florida, 33014, United States|Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001), Philadelphia, Pennsylvania, 19107, United States Less << |
NCT05412173 | Viral Infection|COVID-19 | COMPLETED | 2022-06-02 | Limited Liability Company "Res... More >>earch Center Eco-Safety", Saint Petersburg, 196143, Russian Federation Less << | |
NCT06223932 | COVID-19|SARS-CoV-2 Infection | ACTIVE_NOT_RECRUITING | 2025-02-24 | Istanbul University, Istanbul ... More >>Faculty of Medicine, Department of Infectious Disease, Istanbul, Fatih, 34093, Turkey|Cerrahpasa Faculty of Medicine Infectious Disease Departament, Istanbul, Fatih, Turkey|Ankara City Hospital, Ankara, Turkey|Ankara University Faculty of Medicine, Ankara, Turkey|CAM and SAKURA Training and Research Hospital, Istanbul, Turkey|Istanbul Haseki Training and Research Hospital, Istanbul, Turkey|Koc University Hospital, Istanbul, Turkey|Umraniye Training and Research Hospital, Istanbul, Turkey Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.04mL 0.61mL 0.30mL |
15.18mL 3.04mL 1.52mL |
30.37mL 6.07mL 3.04mL |
Tags: Molnupiravir | EIDD-2801 | MK-4482 | EIDD2801 | EIDD 2801 | MK4482 | MK 4482 | MK-4482 | SARS-CoV | Influenza Virus | SARS coronavirus | influenza | virus | lung | ferrets | seasonal | pandemic | infection| coronaviruses | COVID-19 | inhibitor | 2492423-29-5 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL